We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
-19.92%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$788M
AUM Growth
-$156M
(-16%)
Cap. Flow
-$1.06B
Cap. Flow
% of AUM
-134.35%
Top 10 Holdings %
Top 10 Hldgs %
80.89%
Holding
183
New
45
Increased
18
Reduced
27
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$6.91M |
| 2 |
Vale
VALE
|
+$5.95M |
| 3 |
W.R. Berkley
WRB
|
+$5.25M |
| 4 |
Equitable Holdings
EQH
|
+$4.37M |
| 5 |
Lam Research
LRCX
|
+$4.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Denali Therapeutics
DNLI
|
+$634M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$40.6M |
| 3 |
UnitedHealth
UNH
|
+$35.1M |
| 4 |
Qualcomm
QCOM
|
+$35.1M |
| 5 |
Amazon
AMZN
|
+$34.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 72.44% |
| 2 | Financials | 6.85% |
| 3 | Technology | 5.83% |
| 4 | Materials | 4.33% |
| 5 | Communication Services | 2.1% |
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q1 2021 Portfolio in Review
As of Q1 2021, Crestline Management held 183 positions worth $788M, down 16% from $943M the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Crestline Management withdrew a net $1.06B in Q1 2021, closing 85 positions and reducing 27 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $40.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 72% of assets, up from 41% a quarter earlier, followed by Financials and Technology.
Against the trend, Crestline Management opened a new position in Vale worth $5.93M.
- Crestline Management's largest Q1 2021 buy was Vale: 341,000 shares worth $5.93M.
- Crestline Management added most to Alphabet (Google) Class A in Q1 2021, an estimated $6.91M increase.
- Crestline Management's biggest Q1 2021 reduction was Denali Therapeutics, cutting an estimated $634M.
- Crestline Management fully exited Berkshire Hathaway Class B in Q1 2021, selling an estimated $40.6M.
- Crestline Management's ten largest holdings make up 81% of its $788M portfolio in Q1 2021.
- Crestline Management opened 45 new positions and closed 85 in Q1 2021.
- Crestline Management's portfolio value fell 16% quarter-over-quarter to $788M.
Based on Crestline Management's 13F filing for Q1 2021, filed 14 May 2021.